المؤلفون: Psaros C; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Goodman GR; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Emergency Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Lee JS; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA., Rice W; Department of Behavioral, Social and Health Education Sciences, Emory University Rollins School of Public Health, Atlanta, Georgia, USA., Kelley CF; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Oyedele T; AstraZeneca Pharmaceuticals, Chicago, Illinois, USA., Coelho LE; Instituto Nacional de Infectologia Evandro Chagas-Fiocruz, Rio de Janeiro, Brazil., Phanuphak N; Institute of HIV Research and Innovation, Bangkok, Thailand.; Center of Excellence in Transgender Health, Chulalongkorn University, Bangkok, Thailand., Singh Y; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Middelkoop K; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.; Department of Medicine, University of Cape Town, Cape Town, South Africa., Griffith S; Family Health International 360, Washington, DC, USA., McCauley M; Family Health International 360, Washington, DC, USA., Rooney J; Gilead Sciences, Foster City, California, USA., Rinehart AR; ViiV Healthcare, Durham, North Carolina, USA., Clark J; Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA., Go V; Department of Health Behavior, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, USA., Sugarman J; Berman Institute of Bioethics and School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA., Fields SD; Ross and Carol Nese College of Nursing, The Pennsylvania State University, University Park, Pennsylvania, USA., Adeyeye A; Nigeria Country Office, US Centers for Disease Control and Prevention, Abuja, Nigeria., Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas-Fiocruz, Rio de Janeiro, Brazil., Landovitz RJ; Center for Clinical AIDS Research and Education, David Geffen School of Medicine, University of California, Los Angeles, California, USA., Safren SA; Department of Psychology, University of Miami, Miami, Florida, USA.

مؤلفون مشاركون: HPTN 083‐02 Study Team

المصدر: Journal of the International AIDS Society [J Int AIDS Soc] 2024 May; Vol. 27 (5), pp. e26252.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: Switzerland NLM ID: 101478566 Publication Model: Print Cited Medium: Internet ISSN: 1758-2652 (Electronic) Linking ISSN: 17582652 NLM ISO Abbreviation: J Int AIDS Soc Subsets: MEDLINE

مواضيع طبية MeSH: Pre-Exposure Prophylaxis*/methods , Medication Adherence*/statistics & numerical data , HIV Infections*/prevention & control , HIV Infections*/drug therapy , Anti-HIV Agents*/administration & dosage , Anti-HIV Agents*/therapeutic use, Humans ; Male ; Female ; Adult ; Transgender Persons/psychology ; Homosexuality, Male ; Young Adult ; Pyridones/administration & dosage ; Pyridones/therapeutic use ; Brazil ; Injections ; Pyridines/administration & dosage ; Pyridines/therapeutic use ; Interviews as Topic ; Tenofovir/administration & dosage ; Tenofovir/therapeutic use ; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/administration & dosage ; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/therapeutic use ; Middle Aged ; Diketopiperazines

المؤلفون: Schmidt D; Department of Infectious Disease Epidemiology, Robert-Koch Institute, Berlin, Germany. SchmidtD@rki.de., Duport Y; Project Groups, Robert-Koch Institute, Berlin, Germany., Kollan C; Department of Infectious Disease Epidemiology, Robert-Koch Institute, Berlin, Germany., Marcus U; Department of Infectious Disease Epidemiology, Robert-Koch Institute, Berlin, Germany., Iannuzzi S; Project Groups, Robert-Koch Institute, Berlin, Germany., von Kleist M; Project Groups, Robert-Koch Institute, Berlin, Germany. vkleist@zedat.fu-berlin.de.; Department of Mathematics and Computer Science, Freie Universität Berlin, Berlin, Germany. vkleist@zedat.fu-berlin.de.

المصدر: BMC public health [BMC Public Health] 2024 Jun 25; Vol. 24 (1), pp. 1691. Date of Electronic Publication: 2024 Jun 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE

مواضيع طبية MeSH: Pre-Exposure Prophylaxis*/statistics & numerical data , HIV Infections*/prevention & control , HIV Infections*/epidemiology , COVID-19*/prevention & control , COVID-19*/epidemiology , Anti-HIV Agents*/therapeutic use , Anti-HIV Agents*/administration & dosage, Humans ; Germany/epidemiology ; Male ; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/therapeutic use ; Female ; Models, Theoretical ; Adult

عنوان ترانسليتريتد: Präexpositionsprophylaxe mit Truvada (Tenofovir/Emtricitabin) als eine mögliche Ursache Zöliakie-ähnlicher Enteropathie.

المؤلفون: Pokryszka J; Department of Gastroenterology and Hepatology, Medical University of Vienna, Wien, Austria.; Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Wichlas M; Gruppenpraxis Interne Donaustadt, Vienna, Austria., Vogelsang H; Department of Gastroenterology and Hepatology, Medical University of Vienna, Wien, Austria., Trauner M; Department of Gastroenterology and Hepatology, Medical University of Vienna, Wien, Austria., Herac-Kornauth M; Clinical Institute of Pathology, Medical University of Vienna, Wien, Austria., Kazemi-Shirazi L; Department of Gastroenterology and Hepatology, Medical University of Vienna, Wien, Austria.

المصدر: Zeitschrift fur Gastroenterologie [Z Gastroenterol] 2024 Mar; Vol. 62 (3), pp. 404-406. Date of Electronic Publication: 2023 May 15.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Karl Demeter Verlag Country of Publication: Germany NLM ID: 0033370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-7803 (Electronic) Linking ISSN: 00442771 NLM ISO Abbreviation: Z Gastroenterol Subsets: MEDLINE

مواضيع طبية MeSH: Celiac Disease*, Humans ; Adult ; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination ; Emtricitabine ; Tenofovir ; Duodenum/pathology ; Biopsy ; Intestinal Mucosa/pathology

المؤلفون: Montgomery ET; Women's Global Health Imperative, RTI International, 2150 Shattuck Avenue, Berkeley, CA, 94104, USA. emontgomery@rti.org.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA. emontgomery@rti.org., Hawley I; Women's Global Health Imperative, RTI International, 2150 Shattuck Avenue, Berkeley, CA, 94104, USA., Fairlie L; Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Bunge K; MMWRI, University of Pittsburgh, Pittsburgh, PA, USA., Mathebula F; Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Etima J; Makerere University - Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda., Mutero P; Clinical Trials Research Centre, University of Zimbabwe, Harare, Zimbabwe., Senyama L; Johns Hopkins Project, College of Medicine, University of Malawi, Blantyre, Malawi., Mayo A; FHI 360, Durham, NC, USA., Stoner MCD; Women's Global Health Imperative, RTI International, 2150 Shattuck Avenue, Berkeley, CA, 94104, USA., Piper J; NIAID, Bethesda, MD, USA., Balan I; Department of Behavioral Science and Social Medicine, Florida State University College of Medicine, Tallahassee, FL, USA., van der Straten A; ASTRA Consulting, Kensington, CA, USA.

المصدر: AIDS and behavior [AIDS Behav] 2024 Mar; Vol. 28 (3), pp. 963-973. Date of Electronic Publication: 2023 Nov 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 9712133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-3254 (Electronic) Linking ISSN: 10907165 NLM ISO Abbreviation: AIDS Behav Subsets: MEDLINE

مواضيع طبية MeSH: Anti-HIV Agents*/therapeutic use , Contraceptive Devices, Female* , HIV Infections*/prevention & control , Pyrimidines*, Female ; Humans ; Pregnancy ; Africa/epidemiology ; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination ; Randomized Controlled Trials as Topic ; Clinical Trials, Phase III as Topic

المؤلفون: Okochi H; Division of HIV, Infection Diseases, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.; UCSF-Hair Analytical Laboratory, University of California San Francisco, San Francisco, California, USA., Louie A; Division of HIV, Infection Diseases, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.; UCSF-Hair Analytical Laboratory, University of California San Francisco, San Francisco, California, USA., Phung N; Division of HIV, Infection Diseases, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.; UCSF-Hair Analytical Laboratory, University of California San Francisco, San Francisco, California, USA., Zhang K; Division of HIV, Infection Diseases, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.; UCSF-Hair Analytical Laboratory, University of California San Francisco, San Francisco, California, USA., Tallerico RM; Division of HIV, Infection Diseases, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.; UCSF-Hair Analytical Laboratory, University of California San Francisco, San Francisco, California, USA., Kuncze K; Division of HIV, Infection Diseases, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.; UCSF-Hair Analytical Laboratory, University of California San Francisco, San Francisco, California, USA., Spinelli MA; Division of HIV, Infection Diseases, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA., Koss CA; Division of HIV, Infection Diseases, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA., Benet LZ; UCSF-Hair Analytical Laboratory, University of California San Francisco, San Francisco, California, USA.; Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy and Medicine, University of California San Francisco, San Francisco, California, USA., Gandhi M; Division of HIV, Infection Diseases, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.; UCSF-Hair Analytical Laboratory, University of California San Francisco, San Francisco, California, USA.

المصدر: Drug testing and analysis [Drug Test Anal] 2021 Jul; Vol. 13 (7), pp. 1354-1370. Date of Electronic Publication: 2021 Apr 13.

نوع المنشور: Comparative Study; Journal Article; Validation Study

بيانات الدورية: Publisher: John Wiley & Sons Country of Publication: England NLM ID: 101483449 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-7611 (Electronic) Linking ISSN: 19427603 NLM ISO Abbreviation: Drug Test Anal Subsets: MEDLINE

مواضيع طبية MeSH: Adenine/*analogs & derivatives , Anti-HIV Agents/*analysis , Emtricitabine/*analysis , Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/*analysis , Hair/*chemistry , Tenofovir/*analysis, Adenine/analysis ; Adenine/pharmacokinetics ; Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/pharmacokinetics ; Chromatography, High Pressure Liquid/methods ; Cobicistat/administration & dosage ; Dose-Response Relationship, Drug ; Emtricitabine/pharmacokinetics ; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/administration & dosage ; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/pharmacokinetics ; HIV Infections/drug therapy ; Hair Analysis ; Humans ; Ritonavir/administration & dosage ; Tandem Mass Spectrometry/methods ; Tenofovir/pharmacokinetics ; Tissue Distribution

المؤلفون: Alankar A; Division of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, USA., Tuten J; Division of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, USA., Love T; Division of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, USA., Punsal J; Division of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, USA., Swaminathan S; Division of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, USA., Nyaku AN; Division of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, USA. amesika.nyaku@rutgers.edu.

المصدر: Journal of racial and ethnic health disparities [J Racial Ethn Health Disparities] 2023 Aug; Vol. 10 (4), pp. 1542-1548. Date of Electronic Publication: 2022 Jun 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101628476 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2196-8837 (Electronic) Linking ISSN: 21968837 NLM ISO Abbreviation: J Racial Ethn Health Disparities Subsets: MEDLINE

مواضيع طبية MeSH: Transgender Persons*/psychology , Sexual and Gender Minorities* , HIV Infections*/psychology, Male ; Humans ; Homosexuality, Male ; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination

المؤلفون: Giacomelli A; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.; III Infectious Diseases Unit, Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Luigi Sacco Hospital, Legnano (MI), Italy., Conti F; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.; III Infectious Diseases Unit, Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Luigi Sacco Hospital, Legnano (MI), Italy., Pezzati L; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.; III Infectious Diseases Unit, Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Luigi Sacco Hospital, Legnano (MI), Italy., Oreni L; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy., Ridolfo AL; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.; III Infectious Diseases Unit, Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Luigi Sacco Hospital, Legnano (MI), Italy., Morena V; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.; III Infectious Diseases Unit, Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Luigi Sacco Hospital, Legnano (MI), Italy., Bonazzetti C; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.; III Infectious Diseases Unit, Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Luigi Sacco Hospital, Legnano (MI), Italy., Pagani G; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.; III Infectious Diseases Unit, Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Luigi Sacco Hospital, Legnano (MI), Italy.; Infectious Diseases Unit, Legnano General Hospital, ASST Ovest Milanese, Via G.B. Grassi 74, 20157, Milan, Italy., Formenti T; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy., Galli M; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.; III Infectious Diseases Unit, Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Luigi Sacco Hospital, Legnano (MI), Italy., Rusconi S; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy. stefano.rusconi@unimi.it.; III Infectious Diseases Unit, Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Luigi Sacco Hospital, Legnano (MI), Italy. stefano.rusconi@unimi.it.

المصدر: BMC infectious diseases [BMC Infect Dis] 2021 Jun 22; Vol. 21 (1), pp. 595. Date of Electronic Publication: 2021 Jun 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Anti-HIV Agents/*therapeutic use , Dideoxynucleosides/*therapeutic use , Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/*therapeutic use , Emtricitabine, Rilpivirine, Tenofovir Drug Combination/*therapeutic use , HIV Infections/*drug therapy , Heterocyclic Compounds, 3-Ring/*therapeutic use , Lamivudine/*therapeutic use , Oxazines/*therapeutic use , Piperazines/*therapeutic use , Pyridones/*therapeutic use, Adult ; Anti-HIV Agents/metabolism ; Body Weight/drug effects ; Cohort Studies ; Dideoxynucleosides/metabolism ; Drug Combinations ; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/metabolism ; Emtricitabine, Rilpivirine, Tenofovir Drug Combination/metabolism ; Female ; Heart Disease Risk Factors ; Heterocyclic Compounds, 3-Ring/metabolism ; Humans ; Italy/epidemiology ; Lamivudine/metabolism ; Lipid Metabolism/drug effects ; Lipids/blood ; Male ; Middle Aged ; Oxazines/metabolism ; Piperazines/metabolism ; Pyridones/metabolism ; Retrospective Studies ; Tablets/therapeutic use

المؤلفون: Luscombe CA; Biotron Limited, North Ryde, Australia., Avihingsanon A; HIV-Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.; Tuberculosis Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Supparatpinyo K; Chiang Mai University, Chiang Mai, Thailand., Gatechompol S; HIV-Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.; Tuberculosis Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Han WM; HIV-Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Centre, Bangkok, Thailand., Ewart GD; Biotron Limited, North Ryde, Australia., Thomson AS; Biotron Limited, North Ryde, Australia., Miller M; Biotron Limited, North Ryde, Australia., Becker S; Biotron Limited, North Ryde, Australia., Murphy RL; Northwestern University, Chicago, Illinois, USA.

المصدر: The Journal of infectious diseases [J Infect Dis] 2021 Jun 04; Vol. 223 (11), pp. 1914-1922.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Anti-HIV Agents*/therapeutic use , Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination*/therapeutic use , HIV Infections*/drug therapy , HIV Infections*/immunology, Guanidines/*therapeutic use , Pyrazoles/*therapeutic use, Australia ; CD4-Positive T-Lymphocytes ; CD8-Positive T-Lymphocytes ; Drug Therapy, Combination ; HIV-1 ; Human Immunodeficiency Virus Proteins/antagonists & inhibitors ; Humans ; Inflammation/drug therapy ; Thailand ; Viral Regulatory and Accessory Proteins/antagonists & inhibitors ; Viroporin Proteins/antagonists & inhibitors

المؤلفون: Godinez H; S-3 Research, San Diego, CA, United States., Xu Q; S-3 Research, San Diego, CA, United States.; Global Health Policy and Data Institute, San Diego, CA, United States., McMann TJ; Global Health Policy and Data Institute, San Diego, CA, United States.; Global Health Program, Department of Anthropology, University of California, San Diego, San Diego, CA, United States., Li J; S-3 Research, San Diego, CA, United States., Mackey TK; S-3 Research, San Diego, CA, United States.; Global Health Policy and Data Institute, San Diego, CA, United States.; Global Health Program, Department of Anthropology, University of California, San Diego, San Diego, CA, United States.

المصدر: Frontiers in public health [Front Public Health] 2023 Jun 28; Vol. 11, pp. 1073813. Date of Electronic Publication: 2023 Jun 28 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet ISSN: 2296-2565 (Electronic) Linking ISSN: 22962565 NLM ISO Abbreviation: Front Public Health Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections*/prevention & control , HIV Infections*/drug therapy , Acquired Immunodeficiency Syndrome*/drug therapy , Anti-HIV Agents*/therapeutic use , Sexual and Gender Minorities*, Male ; Adult ; Adolescent ; Humans ; Homosexuality, Male ; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/therapeutic use ; Retrospective Studies ; Emtricitabine/therapeutic use

المؤلفون: Tessema FA; Frazer A. Tessema (ftessema@bwh.harvard.edu), Brigham and Women's Hospital and Harvard University, Boston, Massachusetts; and University of Chicago, Chicago, Illinois., Barenie RE; Rachel E. Barenie, Brigham and Women's Hospital and Harvard University; and University of Tennessee, Memphis, Tennessee., Avorn J; Jerry Avorn, Brigham and Women's Hospital and Harvard University., Kesselheim AS; Aaron S. Kesselheim, Brigham and Women's Hospital and Harvard University.

المصدر: Health affairs (Project Hope) [Health Aff (Millwood)] 2023 May; Vol. 42 (5), pp. 642-649.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Project Hope Country of Publication: United States NLM ID: 8303128 Publication Model: Print Cited Medium: Internet ISSN: 1544-5208 (Electronic) Linking ISSN: 02782715 NLM ISO Abbreviation: Health Aff (Millwood) Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections*/drug therapy , Anti-HIV Agents*/therapeutic use, Humans ; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/therapeutic use ; Pharmaceutical Preparations ; Emtricitabine/therapeutic use ; Tenofovir/therapeutic use